发明授权
US5616492A Monoclonal antibodies differentially reactive with native and
reductively modified Bowman-Birk protease inhibitor
失效
与天然和还原性修饰的Bowman-Birk蛋白酶抑制剂差异反应的单克隆抗体
- 专利标题： Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor
- 专利标题（中）： 与天然和还原性修饰的Bowman-Birk蛋白酶抑制剂差异反应的单克隆抗体
-
申请号： US458353申请日： 1995-06-02
-
公开(公告)号： US5616492A公开(公告)日： 1997-04-01
- 发明人: Ann R. Kennedy , Cameron J. Koch , Edith M. Lord , Xingsheng Wan
- 申请人： Ann R. Kennedy , Cameron J. Koch , Edith M. Lord , Xingsheng Wan
- 申请人地址： PA Philadelphia NY Rochester
- 专利权人： Trustees of the University of Pennsylvania,University of Rochester
- 当前专利权人： Trustees of the University of Pennsylvania,University of Rochester
- 当前专利权人地址： PA Philadelphia NY Rochester
- 主分类号： C07K16/38
- IPC分类号： C07K16/38 ; C07K16/00 ; C12N5/12
摘要：
Monoclonal antibodies and a method capable of detecting BBI metabolites in a sample of body fluid or tissue are provided.